1 微量肝素静滴联合氨溴索雾化吸入辅助治疗支气管肺炎疗效观察【摘要】目的:探讨微量肝素静滴联合氨溴索雾化吸入辅助治疗支气管肺炎疗效。方法:将 82 例支气管肺炎患儿随机分为治疗组(n=42) 和对照组(n=40) ,其中治疗组为在综合治疗的基础上加用微量肝素静滴联合氨溴索雾化吸入治疗, 连续应用 5d。氨溴索采用超声雾化器进行雾化吸入, 连用 5d 。结果: 治疗组临床观察咳嗽,呼吸困难,肺部罗音消失时间, 平均治疗天数均较对照组缩短, 各项指标统计处理两组差异有显著性意义() 。结论: 支气管肺炎在综合治疗的基础上加用微量肝素静滴联合氨溴索雾化吸入治疗疗效显著。【关键词】支气管肺炎素溴索吸入 Abstract:Objective:To explore the the curative effect of micro heparin intravenously and ambroxol aerosol inhalation on bronchopneumonia. Method: 82 cases with bronchopneumonia 2 were randomly divided into two groups,the therapeutic group(N=42) and the control group(N=40). The therapeutic group was given micro heparin intravenously and ambroxol aerosol inhalation for 5 days on the basis bined : The time to remove fever, cough, dyspnea and pulmonary tales and average therapeuti c period was shorter () than that in the control group, there was significant difference () between the therapeutic group and the control group. Conclusion: The micro heparin intravenously and ambroxol aerosol inhalation on bronchopneumonia on the basis bined therapy has significant curative effect. Key words: Bronchopneumonia; Heparin; Ambroxol; Aerosol inhalation 肺炎是儿科最常见的疾病,也是 3 岁以下儿童重要死亡原因,临床对抗感染治疗比较重视,这是十分必要的,但常因忽视其它辅助治疗致临床疗效欠佳。我科在综合治疗的基础上对住院支气管炎患儿加用微量肝素静滴联合氨溴索雾化吸入治疗取得满意疗效。现报道如下: 1 资料和方法 3 一般资料:将 2007 年4 月至 2007 年8 月我院儿科住院确诊的支气管肺炎的患儿 82例, 年龄在 2~ 36 个月, 诊断对照《儿科学》第4 版制定的标准[1
